新型冠状病毒肺炎住院患者新发糖尿病的表型特征及预后：CORONADO 研究结果。
Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study.
机构信息
L'institut du thorax, UNIV Nantes, CHU Nantes, CNRS, Inserm, Département d'Endocrinologie, Diabétologie et Nutrition, CIC Inserm 1413, Hôpital Guillaume et René Laennec, Nantes, France.
L'institut du thorax, UNIV Nantes, CHU Nantes, CNRS, Inserm, Département d'Endocrinologie, Diabétologie et Nutrition, CIC Inserm 1413, Hôpital Guillaume et René Laennec, Nantes, France.
出版信息
Diabetes Res Clin Pract. 2021 May;175:108695. doi: 10.1016/j.diabres.2021.108695. Epub 2021 Feb 10.
In patients with diabetes hospitalized for COVID-19 in CORONADO study, 2.8% had a newly discovered. 2.8% had a newly discovered diabetes (NDD): mean age 60.2 ± 12.5 years and HbA1C 9.0 ± 2.5%. When compared with center, age and sex-matched patients with established type 2 diabetes, NDD was not significantly associated with a more severe COVID-19 prognosis.
在 CORONADO 研究中因 COVID-19 住院的糖尿病患者中，有 2.8%的患者新发糖尿病（NDD）：平均年龄为 60.2 ± 12.5 岁，HbA1C 为 9.0 ± 2.5%。与中心、年龄和性别匹配的 2 型糖尿病患者相比，NDD 与更严重的 COVID-19 预后无显著相关性。
Zotero 插件